Axiron
Product Images NDC 54868-6406

8 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Axiron (NDC 54868-6406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Package Label (54868 6406 0)

Image Of Package Label (54868 6406 0)
AXIRON 30 MG/1.5 ML pump label showing distribution by Physicians Total Care, Inc., NDC 54868-6406-0, with a quantity of 90 mL. The label includes lot number 0000, an expiration date of 01/60, and manufacturing information for Lilly USA, LLC in Indianapolis, IN.*
FDA Label Image

Package Label – Axiron Bottle 30mg 1ct (Axiron 30mg Carton 1 T7891)

Package Label – Axiron Bottle 30mg 1ct (Axiron 30mg Carton 1 T7891)
Packaging label for Axiron (testosterone) topical solution containing 30 mg of testosterone per pump actuation. The multi-dose pump delivers 1.5 mL per actuation, with 60 metered pump actuations per container. The label includes warnings about flammability and instructions to keep out of reach of children, storage conditions, and pharmaceutical details. Marketed by Lilly USA, LLC.*
FDA Label Image

Figure 1 (Axiron mg F001 V1)

Figure 1 (Axiron mg F001 V1)
An instructional illustration showing the components of AXIRON testosterone topical solution packaging, including the bottle with a pump dispenser, a separate cap, and an applicator cup. The bottle label indicates it contains 30 mg of testosterone per pump actuation.*
FDA Label Image

Figure 2 (Axiron mg F002 V1)

Figure 2 (Axiron mg F002 V1)
An instructional illustration showing a hand dispensing AXIRON spray from a pump bottle into a cup held by the other hand. The image provides visual guidance on the proper use of the AXIRON topical solution.*
FDA Label Image

Figure 3 (Axiron mg F003 V1)

Figure 3 (Axiron mg F003 V1)
Illustration showing a man applying a topical solution to the underarm area, holding a container in one hand and using the other hand to rub the product on the skin. The image suggests application of a liquid medication to the armpit.*
FDA Label Image

Structural Formula (Axiron Pi Chem Struct)

Structural Formula (Axiron Pi Chem Struct)
Chemical structure of the active ingredient shown for AXIRON, with a molecular formula of C19H28O2 and a molecular weight of 288.4. The structure depicts several fused rings with various functional groups attached.*
FDA Label Image

Figure 1 (Axiron Pi F001 V1)

Figure 1 (Axiron Pi F001 V1)
A line graph showing serum total testosterone concentration (ng/dL) over time (hours) after dosing with AXIRON at 30 mg, 60 mg, and 90 mg of testosterone. The graph displays mean concentrations with error bars from 0 to 24 hours post dose, illustrating the pharmacokinetic profile of testosterone for each dosage level.*
FDA Label Image

Figure 2 (Axiron Pi F002 V1)

Figure 2 (Axiron Pi F002 V1)
A line graph showing serum total testosterone concentration (ng/dL) over time from dose (hours) for AXIRON. The graph includes data points with error bars and dashed lines indicating the upper and lower limits of normal testosterone levels over a 24-hour period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.